RASAL2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.922600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.203200E-01
Normal-vs-Stage2
8.208800E-01
Normal-vs-Stage3
5.026400E-01
Normal-vs-Stage4
5.393800E-01
Stage1-vs-Stage2
3.377200E-01
Stage1-vs-Stage3
4.778000E-01
Stage1-vs-Stage4
1.237990E-01
Stage2-vs-Stage3
1.580840E-01
Stage2-vs-Stage4
3.749800E-01
Stage3-vs-Stage4
6.486000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.253400E-01
Normal-vs-AfricanAmerican
6.915000E-01
Normal-vs-Asian
9.271000E-01
Caucasian-vs-AfricanAmerican
4.685200E-01
Caucasian-vs-Asian
7.106800E-01
AfricanAmerican-vs-Asian
3.885400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.463800E-01
Normal-vs-Female
9.626400E-01
Male-vs-Female
4.823000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.806000E-01
Normal-vs-Age(41-60Yrs)
5.806200E-01
Normal-vs-Age(61-80Yrs)
9.934800E-01
Normal-vs-Age(81-100Yrs)
8.917000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.910380E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.125600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.165600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.754000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.164180E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.760000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.832000E-01
Normal-vs-Daily Drinker
6.792600E-01
Normal-vs-Weekly Drinker
9.406400E-01
Normal-vs-Occasional Drinker
6.303600E-01
Normal-vs-Social Drinker
7.985600E-01
Non Drinker-vs-Daily Drinker
4.946200E-01
Non Drinker-vs-Weekly Drinker
6.504000E-01
Non Drinker-vs-Occasional Drinker
1.370360E-01
Non Drinker-vs-Social Drinker
3.691800E-01
Daily Drinker-vs-Weekly Drinker
3.380000E-01
Daily Drinker-vs-Occasional Drinker
7.041900E-02
Daily Drinker-vs-Social Drinker
2.052600E-01
Weekly Drinker-vs-Occasional Drinker
3.936000E-01
Weekly Drinker-vs-Social Drinker
6.861200E-01
Occasional Drinker-vs-Social Drinker
7.048400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.357400E-01
Normal-vs-Grade 2
7.002400E-03
Normal-vs-Grade 3
2.564000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.557000E-04
Grade 1-vs-Grade 3
1.142120E-03
Grade 1-vs-Grade 4
1.357400E-01
Grade 2-vs-Grade 3
3.718000E-01
Grade 2-vs-Grade 4
7.002400E-03
Grade 3-vs-Grade 4
2.564000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.236200E-01
Normal-vs-NonDiabetic
9.004000E-01
Diabetic-vs-NonDiabetic
4.662800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.988800E-01
Normal-vs-NoPancreatitis
9.070200E-01
Pancreatitis-vs-NoPancreatitis
3.208800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.790600E-01
Normal-vs-N1
8.189400E-01
N0-vs-N1
5.130000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.151400E-01
Normal-vs-TP53-NonMutant
8.202800E-01
TP53-Mutant-vs-TP53-NonMutant
1.121650E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
